Pfizer Opted Not to Take Feds Money to ‘Liberate Scientists from any Bureaucracy’

Pfizer Opted Not to Take Feds Money to ‘Liberate Scientists from any Bureaucracy’

Pfizer’s CEO Albert Bourla joined Martha Brennan with CBS Face the Nation. An interesting character, he's not just the standard “company man.” The chief declared that in their “base case,” they have “more than a 60% chance” to know whether the experimental vaccine works or not by the end of October. This of course, the CEO reminds, doesn’t mean that it actually works, only that they will know if it works. Bourla reports that given the company is already nearing the 30,000 recruitment mark, the recent expansion to 44,000 for the Phase 3 trial, thanks to high confidence about safety, will involve 16 to 18 year old youth as well as those with “Special conditions and chronic conditions” such as HIV, as well as a more diversified volunteer base. The CEO expresses no concern about the sponsor’s ability to recruit minorities and emphasized that even with over $1 billion at risk (Pfizer opted for no Operation Warp Speed funds), he said it was important to “liberate our scientists from any bureaucracy.”  A CEO that’s cool, confident and collected, some could say with a calmly powerful presence, perhaps the speculation by some top analysts that the Pfizer/BioNTech pair could be in the lead ...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee